Venclaxta Tablet 50 mg contains Venetoclax, a targeted oral therapy used primarily in the treatment of hematologic malignancies, including chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Venetoclax is a BCL-2 inhibitor, which works by promoting apoptosis (programmed cell death) in cancer cells that overexpress the BCL-2 protein. This targeted approach helps reduce tumor burden and manage disease progression effectively.

Venclaxta Tablet 50 mg is part of a carefully titrated dosing regimen, often used in combination with other therapies such as monoclonal antibodies or chemotherapeutic agents, ensuring both efficacy and safety during treatment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Benefits

• Targeted Cancer Therapy: Inhibits BCL-2 protein, selectively inducing death in malignant cells.

• Effective for Hematologic Cancers: Primarily indicated for CLL and SLL, including high-risk patients with 17p deletion.

• Oral Administration: Convenient once-daily dosing without the need for intravenous therapy.

• Combination Therapy Compatible: Can be safely combined with other agents for enhanced treatment outcomes.

• Precision Medicine Approach: Offers effective therapy tailored to patients with specific genetic markers.

Mechanism of Action

Venetoclax works by:

• BCL-2 Inhibition: Blocks the anti-apoptotic BCL-2 protein, allowing cancer cells to undergo programmed cell death.

• Restoring Apoptosis: Targets malignant cells resistant to normal cell death pathways, reducing their survival.

• Enhanced Treatment Response: Supports combination therapy to improve overall efficacy and disease management.

Indications

Venclaxta Tablet 50 mg is indicated for:

• Chronic lymphocytic leukemia (CLL) with or without 17p deletion

• Small lymphocytic lymphoma (SLL)

• Use as part of combination therapy under a hematologist/oncologist’s supervision

• Patients unsuitable for standard chemotherapy

Dosage and Administration

• Typically taken once daily, following a gradual dose escalation schedule to reduce the risk of tumor lysis syndrome (TLS).

• Take with food and a full glass of water to optimize absorption.

• Regular monitoring of blood counts, kidney function, and other laboratory parameters is essential.

• Adherence to prescribed dosing schedules and titration protocols is crucial for safety and efficacy.

Precautions

• Must be used under strict medical supervision with frequent monitoring for TLS.

• Ensure adequate hydration to prevent kidney complications.

• Avoid grapefruit and medications that interact with CYP3A enzymes.

• Pregnancy and breastfeeding are not recommended during treatment unless explicitly advised.

• Inform the physician of all concurrent medications and supplements.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects may include:

• Diarrhea or nausea

• Fatigue

• Low white blood cell count (neutropenia)

• Fever

Serious side effects may include:

• Tumor lysis syndrome

• Severe infections

• Low platelet count or anemia

Seek immediate medical attention if symptoms like sudden weakness, unusual bruising, severe nausea, or confusion occur.

Storage

Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children.